About MAA Laboratories

Transforming Proven Molecules into Next-Generation Therapies

MAA Laboratories Inc. is a technology-driven specialty pharmaceutical company based in Research Triangle Park, North Carolina—a global hub for biotech innovation. We are pioneering the future of drug reformulation and delivery through our proprietary NanoCont™ platform, a next-generation nanoparticle-based drug development and continuous manufacturing technology.

Our mission is to develop clinically differentiated, commercially scalable therapies that overcome longstanding limitations of traditional drug products—such as poor bioavailability, food-effect variability, patient tolerability, and dose-related toxicity.

? The NanoCont™ Advantage

NanoCont™ is a powerful, broadly applicable platform engineered to enhance drug performance across a wide range of molecules, dosage forms, and therapeutic areas. By combining advanced nanoparticle technology with continuous manufacturing principles, we are able to produce formulations that are not only scientifically superior, but also regulatory-aligned, IP-generating, and globally scalable.

Our platform is already enabling the development of innovative products in high-need areas such as:

• Oncology

• Pulmonary and fibrotic diseases

• Autoimmune and inflammatory disorders

• Neurology and cardiovascular conditions

? Global Vision, Real-World Execution

MAA Laboratories is advancing multiple NanoCont™-enabled drug products, with clinical strategies reviewed and accepted by the U.S. FDA, and regulatory engagement underway with Europe, Canada, and other major markets. Our approach uses streamlined Phase I BA/BE studies—without the need for new efficacy or toxicity data—enabling faster development timelines, lower risk, and broader commercial flexibility.

With patents granted in the United States and applications pending globally, and with our platform recognized under the FDA’s Emerging Technology Program, we are ready to scale our innovation to every major market.

? Partner With Us

Whether you’re looking to revitalize existing molecules, unlock new therapeutic potential, or expand your portfolio with differentiated, IP-protected products, MAA Laboratories offers a unique and collaborative opportunity.

Explore how our NanoCont™ platform, global regulatory expertise, and clinical execution capabilities can help bring your next product to market—faster, smarter, and with greater impact.

? Learn more about our Pipeline, NanoCont™ Platform, and Partnership Opportunities.